Norman Sharpless steps down as director of the National Cancer Institute
Norman E. “Ned” Sharpless, M.D., announced today that he has decided to step down from his position as director of the National Cancer Institute (NCI), part of the National Institutes of Health, a position he has held since 2017. Dr. Sharpless will continue as NCI director through April 29, 2022, to allow for a thorough transition. NCI Principal Deputy Director Douglas R. Lowy, M.D., will serve as NCI’s acting director effective April 30, 2022.
“Working at the National Cancer Institute has been the highlight of my career, and I am honored to have had the chance to serve my country in this role, alongside so many talented scientists and administrators,” Dr. Sharpless said. “I leave this job knowing that the talent and passion present at NCI, across the Biden-Harris Administration and throughout the cancer research community will continue to fuel tremendous progress for people with cancer in the years ahead.”
Dr. Sharpless was sworn in as the 15th director of NCI on Oct. 17, 2017. He also served as Acting Commissioner for Food and Drugs at the U.S. Food and Drug Administration (FDA) for seven months in 2019, before returning to the NCI directorship.
National Cancer Institute Director Norman E. “Ned” Sharpless, M.D.
This page was last updated on Friday, May 13, 2022